Sirolimus-Eluting Stents for the Treatment of Obstructive Superficial Femoral Artery Disease

Abstract

The use of sirolimus-eluting SMART stents for superficial femoral artery occlusion is feasible, with a trend toward reducing late loss compared with uncoated stents. The coated stent also proved to be safe and was not associated with any serious adverse events.